Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.27
-0.04 (-0.35%)
Nov 21, 2024, 4:00 PM EST - Market closed
Stoke Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Stoke Therapeutics stock have an average target of 21.4, with a low estimate of 13 and a high estimate of 35. The average target predicts an increase of 89.88% from the current stock price of 11.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for STOK stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +210.56% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +95.21% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +210.56% | Sep 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +95.21% | Aug 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $17 | Buy | Reiterates | $17 | +50.84% | Jul 11, 2024 |
Financial Forecast
Revenue This Year
16.83M
from 8.78M
Increased by 91.67%
Revenue Next Year
17.75M
from 16.83M
Increased by 5.45%
EPS This Year
-2.10
from -2.38
EPS Next Year
-2.54
from -2.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.8M | 68.3M | 78.8M | ||
| Avg | 16.8M | 17.7M | 25.6M | ||
| Low | 11.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 126.0% | 305.5% | 343.8% | ||
| Avg | 91.7% | 5.4% | 44.5% | ||
| Low | 33.9% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.10 | -2.36 | -2.29 | ||
| Avg | -2.10 | -2.54 | -2.55 | ||
| Low | -2.23 | -2.85 | -2.98 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.